+948.4%
MRNA vs AME
+228.6%
+719.8%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | AME | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -3.6% | +1.4% | -1.0% |
| 7D | -12.7% | -7.9% | -4.8% | -10.3% |
| 30D | -20.7% | -10.9% | -9.7% | -17.6% |
| 3M | +46.3% | -6.6% | +52.9% | +49.6% |
| 6M | +305.2% | -0.5% | +305.7% | +300.3% |
| YTD | +561.2% | +9.1% | +552.2% | +531.8% |
| 1Y | +772.1% | +18.0% | +754.1% | +710.2% |
| 3Y | +147.0% | +46.8% | +100.2% | +117.3% |
| 5Y | -26.1% | +61.6% | -87.7% | -37.8% |
| All | +948.4% | +228.6% | +719.8% | +570.7% |
Cumulative growth
Daily Returns
Daily percentage return beside AME.
Daily Out/Under-Performance
Portfolio return minus AME return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AME return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded AME wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling